AstraZeneca PLC
AZN· NYSE
AZNAstraZeneca PLC
Quarterly figures for AstraZeneca PLC, with source filings when available.
10 quarters. Jun 30, 2016 to Jun 30, 2025. USD.
Filing lag not yet established. Fewer than two comparable filings are on file.
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2025 | |||||||||
| Q2 2025 | Jun 30, 2025 | ||||||||
AstraZeneca PLC · CIK 901832 · Engraved from SEC EDGAR
| — |
| — |
| — |
| — |
| $14.46B |
| +11.7% |
| $1.57 |
| FY 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2024 | Jun 30, 2024 | — | — | — | — | $12.94B | +13.3% | $1.24 | |
| FY 2023 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2023 | Jun 30, 2023 | — | — | — | — | $11.42B | +6.0% | $1.17 | |
| FY 2022 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2022 | Jun 30, 2022 | — | — | — | — | $10.77B | +31.0% | $0.23 | |
| FY 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2021 | Jun 30, 2021 | — | — | — | — | $8.22B | +31.0% | $0.42 | |
| FY 2020 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2020 | Jun 30, 2020 | — | — | — | — | $6.28B | +7.8% | $0.58 | |
| FY 2019 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2019 | Jun 30, 2019 | — | — | — | — | $5.82B | +13.0% | $0.10 | |
| FY 2018 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2018 | Jun 30, 2018 | — | — | — | — | $5.16B | +2.1% | $0.27 | |
| FY 2017 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2017 | Jun 30, 2017 | — | — | — | — | $5.05B | −7.6% | $0.38 | |
| FY 2016 | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Q2 2016 | Jun 30, 2016 | — | — | — | — | $5.47B | — | — | |
